This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following Federal Advisory Committee meeting.
Name: National Vaccine Advisory Committee (NVAC).
Times and Date: 10 a.m.-1 p.m., October 2, 2001.
Place: Audio Conference Call.
Status: This meeting is open to the public, telephone lines are limited. The public can join the meeting by Audio Conference Call by calling (888) 396-9928 and providing the following information:
Leaders Name: Sagar.
Purpose: This committee advises and makes recommendations to the Director of the National Vaccine Program on matters related to the Program responsibilities.
Matters To Be Discussed: Agenda items will include, but not be limited to: A report from the National Vaccine Program Office (NVPO) and the Interagency Vaccine Workgroup; Institute of Medicine (IOM) Report on Thimerasol in Vaccines; a report on the Workgroup on Public Health Options for Implementing Vaccine Recommendations Regional Meetings; an update on Vaccine Supply and a Report from the NVAC Vaccine Supply Workgroup; and a discussion of future priorities of the IOM Vaccine Safety Committee.
Agenda items are subject to change as priorities dictate.
Pubic comments will be permitted at the end of the NVAC meeting on October 2, 2001.
An unavoidable administrative delay prevented meeting the 15-day publication requirement.Start Further Info
CONTACT PERSON FOR MORE INFORMATION:
Gloria Sagar, Committee Management Specialist, NVPO, CDC, 4770 Buford Highway, M/S K-77, Atlanta, Georgia 30333, telephone (770)488-2040.
The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: September 24, 2001.
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 01-24303 Filed 9-27-01; 8:45 am]
BILLING CODE 4163-18-P